المؤلفون: V. Syutkin E., V. Gorodetskiy R., A. Salienko A., N. Probatova A., N. Kupryshina A., M. Novruzbekov S., В. Сюткин Е., В. Городецкий Р., А. Салиенко А., Н. Пробатова А., Н. Купрышина А., М. Новрузбеков С.

المصدر: Transplantologiya. The Russian Journal of Transplantation; Том 13, № 3 (2021); 272-279 ; Трансплантология; Том 13, № 3 (2021); 272-279 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2021-13-3

مصطلحات موضوعية: liver transplantation, post-transplant lymphoproliferative diseases, proliferation signal inhibitors, everolimus, трансплантация печени, посттрансплантационные лимфопролиферативные заболевания, ингибиторы пролиферативного сигнала, эверолимус

وصف الملف: application/pdf

العلاقة: https://www.jtransplantologiya.ru/jour/article/view/587/638Test; https://www.jtransplantologiya.ru/jour/article/view/587/644Test; Doak PB, Montgomerie JZ, North JD, Smith F. Reticulum cell sarcoma after renal homotransplantation and azathioprine and prednisone therapy. Br Med J. 1968;4(5633):746–748. PMID: 4881420 https://doi.org/10.1136/bmj.4.5633.746Test; Starzl TE, Nalesnik MA, Porter KA, Ho M, Iwatsuki S, Griffith BP, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet. 1984;1(8377):583–587. PMID: 6142304 https://doi.org/10.1016/s0140-6736Test(84)90994-2; Swerdlow S. Post-transplant lymphoproliferative disorders. In: WHO classification of tumours of haematopoietic and lymphoid tissues. 4 th ed. Lyon: International Agency for Research on Cancer; 2017. p. 453–462.; Taylor AL, Marcus R, Bradley JA. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation. Crit Rev Oncol Hematol. 2005;56(1):155–167. PMID: 15979320 https://doi.org/10.1016/j.critrevonc.2005.03.015Test; Soutar R, Lucraft H, Jackson G, Reece A, Bird J, Low E, et al. Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Br J Haematol. 2004;124(6):717–726. PMID: 15009059 https://doi.org/10.1111/j.1365-2141.2004.04834.xTest; Kilciksiz S, Karakoyun-Celik O, Agaoglu FY, Haydaroglu A. A review for solitary plasmacytoma of bone and extramedullary plasmacytoma. Sci World J. 2012;2012:895765. PMID: 22654647 https://doi.org/10.1100/2012/895765Test; Trappe R, Zimmermann H, Fink S, Reinke P, Dreyling M, Pascher A, et al. Plasmacytoma-like post-transplant lymphoproliferative disorder, a rare subtype of monomorphic B-cell posttransplant lymphoproliferation, is associated with a favorable outcome in localized as well as in advanced disease: a prospective analysis of 8 cases. Haematologica. 2011;96(7):1067–1071. PMID: 21719885 https://doi.org/10.3324/haematol.2010.039214Test; Richendollar BG, Hsi ED, Cook JR. Extramedullary plasmacytoma-like posttransplantation lymphoproliferative disorders: clinical and pathologic features. Am J Clin Pathol. 2009;132(4):581– 588. PMID: 19762536 https://doi.org/10.1309/AJCPX70TIHETNBRLTest; Al-Mansour Z, Nelson BP, Evens AM. Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies. Curr Hematol Malig Rep. 2013;8(3):173–183. PMID: 23737188 https://doi.org/10.1007/s11899-013-0162-5Test; El-Salem M, Raghunath PN, Marzec M, Wlodarski P, Tsai D, Hsi E, et al. Constitutive activation of mTOR signaling pathway in post-transplant lymphoproliferative disorders. Lab Invest. 2007;87(1):29–39. PMID: 17075574 https://doi.org/10.1038/labinvest.3700494Test; Nepomuceno RR, Balatoni CE, Natkunam Y, Snow AL, Krams SM, Martinez OM. Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein Barr virus B-cell lymphomas. Cancer Res. 2003;63(15):4472–4480. PMID: 12907620; Majewski M, Korecka M, Kossev P, Li S, Goldman J, Moore J, et al. The immunosuppressive macrolide RAD inhibits growth of human Epstein-Barr virus-transformed B lymphocytes in vitro and in vivo: A potential approach to prevention and treatment of posttransplant lymphoproliferative disorders. Proc Natl Acad Sci USA. 2000;97(8): 4285–4290. PMID: 10759564 https://doi.org/10.1073/pnas.080068597Test; Majewski M, Korecka M, Joergensen J, Fields L, Kossev P, Schuler W, et al. Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft-protecting doses. Transplantation. 2003;75(10):1710–1717. PMID: 12777861 https://doi.org/10.1097/01.TP.0000063934.89714.19Test; Cullis B, D'Souza R, McCullagh P, Harries S, Nicholls A, Lee R, et al. Sirolimus- induced remission of posttransplantation lymphoproliferative disorder. Am J Kidney Dis. 2006;47(5):e67–72. PMID: 16632009 https://doi.org/10.1053/j.ajkd.2006.01.029Test; Boratynska M, Smolska D. Inhibition of mTOR by sirolimus induces remission of post-transplant lymphoproliferative disorders. Transpl Int. 2008;21(6):605– 608. PMID: 18282244 https://doi.org/10.1111/j.1432-2277.2008.00655.xTest; Pascual J. Post-transplant lymphoproliferative disorder--the potential of proliferation signal inhibitors. Nephrol Dial Transplant. 2007;22(Suppl 1): i27–35. PMID: 17456616 https://doi.org/10.1093/ndt/gfm088Test; Nanmoku K, Shinzato T, Kubo T, Shimizu T, Yagisawa T. Remission of Epstein-Barr virus-positive post-transplant lymphoproliferative disorder by conversion to everolimus in a kidney transplant recipient. Transpl Infect Dis. 2019;21(4):e13116. PMID: 31102475 https://doi.org/10.1111/tid.13116Test; Li J, Liu Z, Li Y, Jing Q, Wang H, Liu H, et al. Everolimus shows synergistic antimyeloma effects with bortezomib via the AKT/mTOR pathway. J Investig Med. 2019;67(1):39–47. PMID: 29997148 https://doi.org/10.1136/jim-2018-000780Test; Günther A, Baumann P, Burger R, Kellner C, Klapper W, Schmidmaier R, et al. Activity of everolimus (RAD001) in relapsed and/or refractory multiple myeloma: a phase I study. Haematologica. 2015;100(4):541–547. PMID: 25682600 https://doi.org/10.3324/haematol.2014.116269Test; Brennan DC, Aguado JM, Potena L, Jardine AG, Legendre C, Säemann MD, et al. Effect of maintenance immunosuppressive drugs on virus pathobiology: evidence and potential mechanisms. Rev Med Virol. 2013;23(2):97–125. PMID: 23165654 https://doi.org/10.1002/rmv.1733Test; Pascual J, Royuela A, Fernández AM, Herrero I, Delgado JF, Solé A, et al. Role of mTOR inhibitors for the control of viral infection in solid organ transplant recipients. Transpl Infect Dis. 2016;18(6):819–831. PMID: 27600985 https://doi.org/10.1111/tid.12601Test; https://www.jtransplantologiya.ru/jour/article/view/587Test

الإتاحة: https://doi.org/10.23873/2074-0506-2021-13-3-272-279Test
https://doi.org/10.23873/2074-0506-2021-13-3Test
https://doi.org/10.1136/bmj.4.5633.746Test
https://doi.org/10.1016/s0140-6736Test(84)90994-2
https://doi.org/10.1016/j.critrevonc.2005.03.015Test
https://doi.org/10.1111/j.1365-2141.2004.04834.xTest
https://doi.org/10.1100/2012/895765Test
https://doi.org/10.3324/haematol.2010.039214Test
https://doi.org/10.1309/AJCPX70TIHETNBRLTest
https://doi.org/10.1007/s11899-013-0162-5Test

المؤلفون: Vladimir Vasilyev Ivanovich, V Gorodetsky R, S Sedyshev Kh, O Logvinenko A, N Probatova A, A Pavlovskaya I, M Eliseyev S, A Smirnov V, G Fadienko R, В. Васильев И., В. Городецкий Р., С. Седышев Х., О. Логвиненко А., Н. Пробатова А., А. Павловская И., А. Смирнов В.

المصدر: Rheumatology Science and Practice; Vol 51, No 2 (2013); 205-209 ; Научно-практическая ревматология; Vol 51, No 2 (2013); 205-209 ; 1995-4492 ; 1995-4484 ; 10.14412/1995-4484-2013-2

العلاقة: Демидова А.В., Хорошко Н.Д. Сублейкемический миелоз. В кн.: Руководство по гематологии. Под ред. академика А.И. Воробьева. М.: Ньюдиамед, 2003;2:16-20 Spivak J.L. The chronic myeloproliferative disorders: clonality and clinical heterogeneity. Semin Hematol 2004;41(Suppl 3):1-5. Baxter E.J., Scott L.M., Campbell PJ. et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 2005;365:1054-61. Heinicke M.H., Zarrabi M.H., Gorevic P.D. Arthritis due to synovial involvement by extramedullary haemotopoiesis in myelofibrosis with myeloid metaplasia. Ann Rheum Dis 1983;42:196-200. McCarty D.M. Fibrosis of the bone marrow: content and causes. Br J Haemat 1985;59:1-7. Lichtman M.A. Primary myelofibrosis. Ch.91. Williams Hematology. 8th еd. Eds Kaushansky K., Lichtman M.A., Beuter E., Kipps T.J., Seligsohn V., Prchal J.T. McGraw-Hill Companies, 2010. Marie I., Levesque H., Cailleux N. et al. An uncommon association: Sjogren’s syndrome and autoimmune myelofibrosis. Rheumatology 1999;38:370. Васильев В.И., Симонова М.В., Сафонова Т.Н. Критерии диагноза болезни и синдрома Шегрена. В кн.: Избранные лекции по клинической ревматологии. Под ред. В.А. Насоновой, Н.В. Бунчука. М.: Медицина, 2001;112—31. Altman A. Acute tumor lysis syndrome. Sem Oncol 2001;28(Suppl):3-8. American Society of Health-System Pharmacists. ASHP guidelines on handling hazardous drugs. Am J Health-Syst Pharm 2006;63:1172-93. Arnold T.M., Reuter J.P., Delman B.S., Shanholtz C. Use of single-dose Rasburicase in an obese female. Ann Pharmacoter 2004;38:1428-31. Насонов Е.Л., Александрова Е.Н. Применение Ритуксимаба при ревматоидном артрите. Науч-практич ревматол 2010;4(Прил. 1):10-40. Spivak J.L. Polycythemia vera and other myeloproliferative disease. 17th ed. Harrison’s Principles of International Medicine. Eds Fauci A.S., Braunwald E., Kasper D.L., Hauser S.L., Longo D.L., Jameson J.L., Loscalzo J. Mеdical Mc Graw-Hill, 2008:671-3. Jacobson R.I., Salo A., Fialkow PJ. Agnogenic myeloid metaplasia: a clonal proliferation of hematopoetic stem cells with secondary myelofibrosis. Blood 1978;51:189-94. Логвиненко О.А., Васильев В.И. Неходжкинские лимфомы при ревматических заболеваниях. Науч-практич ревматол 2011;5:71-83. Васильев В.И., Пробатова Н.А., Тупицын Н.Н. и др. Лимфопролиферативные заболевания при болезни Шегрена. Онкогематология 2007;3:16-26. Васильев В.И. Болезнь Шегрена: клинико-лабораторные, иммуноморфологические проявления и прогноз: Автореф. дис. д-ра мед. наук. М., 2007:1-46. Exposito R.S., Moreno R.J., Reolid C.E. et al. Idiopathic myelofibrosis associated with rheumatoid arthritis. Med Clin (Barc) 1994;102:277. Jain V., Baheshwari A., Gulati S. et al. Juvenile rheumatoid arthritis with myelofibrosis with myeloid metaplasia. Ind J Ped 2005;72:789-91. Ong A., Quach H., Lech M. et al. Reversal of of transfusion depence by TNF-inhibitor treatment a patient with concurrent Ra and primary myelofibrosis. J Clin Rheum 2011;17:211-3. Pavithram K., Thomas M. Chronic myeloid leukemia presenting as gout. Clin Rheumatol 2001;20:288-9. Teferri A., Vardiman J.W. Classification and diagnosis of myeloproliferative neoplasms. The 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 2008;22:14-22.; https://rsp.mediar-press.net/rsp/article/view/788Test

الإتاحة: https://doi.org/10.14412/1995-4484-2013-650Test
https://doi.org/10.14412/1995-4484-2013-2Test
https://rsp.mediar-press.net/rsp/article/view/788Test

المؤلفون: Vladimir Vasilyev Ivanovich, Н Пробатова А, В Городецкий Р, С Пальшина Г, S Radenska-Lopovok G, Yu Sidorova V, G Fadienko R, O Mukhortova V

المصدر: Rheumatology Science and Practice; Vol 51, No 3 (2013); 346-351 ; Научно-практическая ревматология; Vol 51, No 3 (2013); 346-351 ; 1995-4492 ; 1995-4484 ; 10.14412/1995-4484-2013-3

وصف الملف: application/pdf

العلاقة: https://rsp.mediar-press.net/rsp/article/view/1661/1152Test; https://rsp.mediar-press.net/rsp/article/view/1661Test

الإتاحة: https://doi.org/10.14412/1995-4484-2013-1512Test
https://doi.org/10.14412/1995-4484-2013-3Test
https://rsp.mediar-press.net/rsp/article/view/1661Test

المؤلفون: V. Vasilyev I., S. Sedyshev Kh., V. Gorodetskii R., S. Radenska-Lopovok G., E. Rodionova B., O. Logvinenko A., N. Probatova A., E. Varlamova Yu., A. Dmitriev A., В. Васильев И., С. Седышев Х., В. Городецкий Р., С. Раденска-Лоповок Г., Е. Родионова Б., О. Логвиненко А., Н. Пробатова А., Е. Варламова Ю., А. Дмитриев А.

المصدر: Rheumatology Science and Practice; Vol 49, No 5 (2011); 92-97 ; Научно-практическая ревматология; Vol 49, No 5 (2011); 92-97 ; 1995-4492 ; 1995-4484 ; 10.14412/1995-4484-2011-3

وصف الملف: application/pdf

العلاقة: https://rsp.mediar-press.net/rsp/article/view/1639/1185Test; https://rsp.mediar-press.net/rsp/article/view/1639Test

الإتاحة: https://doi.org/10.14412/1995-4484-2011-1467Test
https://doi.org/10.14412/1995-4484-2011-3Test
https://rsp.mediar-press.net/rsp/article/view/1639Test

المؤلفون: Vadim Gorodetsky Romanovich, Н Пробатова А, O Logvinenko A, В Васильев И, M Ogorodnikova D, С Седышев Х, М Симонова В, Т Сафонова Н, M Varlamova Yu, L Mekheda V, N Malakhova V, Евгений Насонов Львович

المصدر: Rheumatology Science and Practice; Vol 48, No 2 (2010); 103-106 ; Научно-практическая ревматология; Vol 48, No 2 (2010); 103-106 ; 1995-4492 ; 1995-4484 ; 10.14412/1995-4484-2010-2

مصطلحات موضوعية: rheumatoid arthritis, Sjogren's syndrome, MALT lymphoma, multiple myeloma, ревматоидный артрит, синдромом Шегрена, MALT-лимфома, множественная миелома

وصف الملف: application/pdf

العلاقة: https://rsp.mediar-press.net/rsp/article/view/1631/1125Test; https://rsp.mediar-press.net/rsp/article/view/1631Test

الإتاحة: https://doi.org/10.14412/1995-4484-2010-1423Test
https://doi.org/10.14412/1995-4484-2010-2Test
https://rsp.mediar-press.net/rsp/article/view/1631Test

المؤلفون: V Vasil'ev I, V Gorodetskiy R, S Sedyshev Kh, N Probatova A, A Pavlovskaya I, M Varlamova Yu, S Pal'shina G, A Logunov L, O Logvinenko A, E Sokol V, E Nasonov L, V Vasilyev I, V Gorodetsky R, S Palshina G, O Logvinenko, С. Седышев Х., Н. Пробатова А., А. Павловская И., А. Логунов Л., О. Логвиненко А., Евгений Насонов Львович, В. Васильев И., В. Городецкий Р., С. Пальшина Г.

المصدر: Rheumatology Science and Practice; Vol 48, No 1 (2010); 81-87 ; Научно-практическая ревматология; Vol 48, No 1 (2010); 81-87 ; 1995-4492 ; 1995-4484 ; 10.14412/1995-4484-2010-1

مصطلحات موضوعية: myeloma, vasculitis, immunoglobulins, cryoglobulins, sepsis, миелома, васкулит, иммуноглобулины, криоглобулины, сепсис

وصف الملف: application/pdf

العلاقة: https://rsp.mediar-press.net/rsp/article/view/1249/920Test; Wintrobe M.M., Buell M.V. Hyperproteinemia associated with multiple myeloma. With report of a case in wich an extraordinary hyperproteinemia was associated with trombosis of retinal veins and symptomas suggesting Raynauds disease. Bull Johns Hopkins Hosp 1933;52:156. Brouet J.-C., Clauvel J.-P., Danon F. et al. Biologic and clinical significance of cryoglobulins. Review. A report of 86 cases. Amer J Med 1974;57:775-87. Goveric P.D., Kassab H.J., Levo Y. et al. Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Review. Amer J Med 1980;69:287-307. Константинова Н.А. Криоглобулины и патология. М., Медицина, 1999. Anfimova M.L., Lebedeva T.V., Vassiliev V.I. et al. Fibronectin, cryoglobulinemia and immune complexes of patients with Sjogren's syndrome. Rus J Immun 1996;1:30-4. Белинин Г.Ю., Васильев В.И., Ефремов Е.Е., Васильев С.А. Клиническая эффективность криоафереза у больных с криоглобулинемиями. Тромбоз, гемостаз и реология 2004;4:20,45-55. Braun G.S., Horster S., Wagner K.S. et al. Cryoglobulinaemic vasculitis: classification and clinical and therapeutic aspects. Review. Postgrad Med J 2007;83:87-94. Васильев В.И., Ходарев Н.В., Мач Э.С. и др. Криоглобулинемия при болезни Шегрена. Тер. архив 1990;5:66-70. Васильев В.И., Пробатова Н.А., Варламова Е.Ю. и др. Прогностическое значение смешанной моноклональной криоглобулинемии при болезни Шeгрена. Тер. архив 2004;8:61-68. Мануйлова Л.С. Клинико-морфологические изменения сосудов при болезни Шегрена: Дис. … канд. мед. наук. М., 1992. Ferri C., Sebastiani M., Giuggiali D. et al. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum 2004;33:355-74. Tedeschi F., Barate C., Minola E., Morra E. Cryoglobulinemia. Review. Blood Reviews 2007;21:183-200. Васильев В. И., Пробатова Н.В., Тупицин Н.Н. и др. Лимфопролиферативные заболевания при болезни Шёгрена. Онкогематология 2007;3:16-26. Вотякова О.Н., Демина Е.А. Множественная миелома. Клиническая онкогематология. Под ред. М.А. Волковой. М., Медицина, 2001; с. 423-49. Андреева Н.Е., Балакирева Т.В. Множественная миелома. Руководство по гематологии. Т. 2. Под ред. А.И. Воробьева. М., Ньюдиамед, 2003; с. 151-73. Naschitz J.E. Rheumatic syndromes: сlues to occult neoplasia. Curr Opin Rheumatol 2001;13:62-6. Vital E.M., Emery P. Rheumatological manifestations of malignant heamatological conditions. Topical Reviews. Reports on the rheumatic diseases, series 5. 2007;11:1-8. Логвиненко О.А., Васильев В.И. Ассоциация между болезнью Шёгрена и лимфомами. Науч.-практ. ревматол. 2006;3:67-76. Тrejo O., Ramos-Casals M., Lopez-Guillermo A. et al. Hematologic malignancies in patients with cryoglobulinemia association with autoimmune and chronic viral diseases. Semin Arthr Rheum 2003;33:19-28. Palshina S.G., Vasiliev V.I. Primary and secondary Sjogren's syndrome in patients with chronic hepatobiliary diseases. 10th International symposium on Sjogren's syndrome. Abstract book. 2009; 120. Логвиненко О.А., Васильев В.И., Ковригина А.М. и др. Ритуксимаб в лечении нодальной В-клеточной лимфомы маргинальной зоны, болезни Шёгрена и аутоиммунного гепатита. Науч.-практ. ревматол. 2008;5:64-71. Logvinenko O.A., Vasilyev V.I., Simonova M.V. et al. Prognostic significance of monoclonal immunoglobulins in primary Sjogren's syndrome. Ann Rheum Dis 2005; 111(Suppl.):307. Blade J., Kyle R.A. Monoclonal gammopathies of undertermined significance. Myeloma. Biology and management. Eds Malpas J.S., Bersagel D.E., Kyle R.A., Anderson K.S. Oxford medical publications, 1998; p. 514-41. Городецкий В.Р., Пробатова Н.А., Васильев В.И. и др. Первичная плазмоци-тома лимфатических узлов. Гематол. и трансфузиол. 2006;51:3-8. Cancer. Principles and practice of oncology. Vol.2. 5th ed. Eds De Vita V.T., Heliman S., Rosenberg S.A. Philadelphia, Lippincott-Raven Publishers, 1997. Munford R.S. Severe sepsis and septic shock: the role of gram-negative bacteremia. Annu Rev Pathol Mech Dis 2006;1:467-77. Treatment of Multiple Myeloma and Related Disorders. Eds Rajkumar S.V., Kyle R.A. Cambridge University Press, 2009; p. 1-195. Бессмельцев С.С., Карягина Е.В., Стельмашенко Л.В. и др. Бортезамид (Велкейд) в комбинации с дексаметазоном в лечении рефрактерных/рецидивирующих форм множественной миеломы. Результаты заключительного анализа. Клин. онкогематол. 2009;2:236-45. Dispenzieri A., Merlini G., Comenzo R.L. Amyloidosis: 2008 BMT Tandem Meetings (February 13-17, San Diego). Biol of Blood Marrow Transplant 2008;14:6-11.; https://rsp.mediar-press.net/rsp/article/view/1249Test

الإتاحة: https://doi.org/10.14412/1995-4484-2010-1410Test
https://doi.org/10.14412/1995-4484-2010-1Test
https://rsp.mediar-press.net/rsp/article/view/1249Test